Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Nanotechnology|June 2, 2020
Fe doped SrWO4 with tunable band structure for photocatalytic nitrogen fixationQiang Li, Xiaoxia Bai, Jingying Luo, et al.
Pharmacogenomics and Personalized Medicine|December 2, 2020
Should CYP2C19 Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus?Jialin Sun, Ping Leng, Chen Sun, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2008
Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatusChao Dai, Yibao Ma, Zhenhuan Zhao, et al.
The Journal of Biological Chemistry|July 14, 2012
Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivoZhenhuan Zhao, Wei Hong, Zhengyang Zeng, et al.
Annals of the Rheumatic Diseases|September 27, 2018
Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversificationZhenhuan Zhao, Jiling Ren, Chao Dai, et al.
Frontiers in Immunology|November 17, 2022
HLA-DR3 restricted environmental epitopes from the bacterium Clostridium tetani have T cell cross-reactivity to the SLE-related autoantigen SmDZhenhuan Zhao, Ashley N Anderson, Carol C Kannapell, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2009
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculatesZhenhuan Zhao, Yibao Ma, Chao Dai, et al.
Molecular Biology Reports|June 25, 2008
Recombinant hirudin treatment modulates aquaporin-4 and aquaporin-9 expression after intracerebral hemorrhage in vivoZhe Sun, Zhenhuan Zhao, Shiguang Zhao, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 21, 2023
Advanced Interface Engineering in Gradient Core/Shell Quantum Dots Enables Efficient Photoelectrochemical Hydrogen EvolutionHui Zhang, Jiabin Liu, Lucas V Besteiro, et al.
International Journal of Molecular Sciences|June 26, 2026
CD22 as a Target for Hematological Malignancies and Autoimmune DiseasesXin Chen, Jiayi Zhang, Sizhuo Chen, et al.
Pageof 6